Ajanta Pharma Statistics

Total Valuation

Ajanta Pharma has a market cap or net worth of INR 350.15 billion. The enterprise value is 343.06 billion.

Market Cap	350.15B
Enterprise Value	343.06B

Important Dates

The next estimated earnings date is Monday, January 27, 2025.

Earnings Date	Jan 27, 2025
Ex-Dividend Date	Nov 6, 2024

Share Statistics

Ajanta Pharma has 124.89 million shares outstanding. The number of shares has decreased by -1.05% in one year.

Current Share Class	n/a
Shares Outstanding	124.89M
Shares Change (YoY)	-1.05%
Shares Change (QoQ)	-0.33%
Owned by Insiders (%)	53.63%
Owned by Institutions (%)	21.65%
Float	41.84M

Valuation Ratios

The trailing PE ratio is 40.28 and the forward PE ratio is 34.31. Ajanta Pharma's PEG ratio is 1.81.

PE Ratio	40.28
Forward PE	34.31
PS Ratio	7.84
PB Ratio	9.56
P/TBV Ratio	9.56
P/FCF Ratio	38.37
P/OCF Ratio	n/a
PEG Ratio	1.81

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.19, with an EV/FCF ratio of 37.59.

EV / Earnings	39.21
EV / Sales	7.64
EV / EBITDA	27.19
EV / EBIT	30.36
EV / FCF	37.59

Financial Position

The company has a current ratio of 3.07, with a Debt / Equity ratio of 0.01.

Current Ratio	3.07
Quick Ratio	1.93
Debt / Equity	0.01
Debt / EBITDA	0.03
Debt / FCF	0.04
Interest Coverage	104.92

Financial Efficiency

Return on equity (ROE) is 24.45% and return on invested capital (ROIC) is 19.55%.

Return on Equity (ROE)	24.45%
Return on Assets (ROA)	15.31%
Return on Capital (ROIC)	19.55%
Revenue Per Employee	5.56M
Profits Per Employee	1.08M
Employee Count	8,073
Asset Turnover	0.97
Inventory Turnover	1.40

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +42.45% in the last 52 weeks. The beta is 0.09, so Ajanta Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	+42.45%
50-Day Moving Average	2,967.27
200-Day Moving Average	2,673.41
Relative Strength Index (RSI)	39.79
Average Volume (20 Days)	115,224

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ajanta Pharma had revenue of INR 44.91 billion and earned 8.75 billion in profits. Earnings per share was 69.60.

Revenue	44.91B
Gross Profit	33.48B
Operating Income	11.30B
Pretax Income	11.81B
Net Income	8.75B
EBITDA	12.50B
EBIT	11.30B
Earnings Per Share (EPS)	69.60

Full Income Statement

Balance Sheet

The company has 7.42 billion in cash and 327.90 million in debt, giving a net cash position of 7.09 billion or 56.78 per share.

Cash & Cash Equivalents	7.42B
Total Debt	327.90M
Net Cash	7.09B
Net Cash Per Share	56.78
Equity (Book Value)	36.77B
Book Value Per Share	293.33
Working Capital	18.86B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.63 billion and capital expenditures -2.50 billion, giving a free cash flow of 9.13 billion.

Operating Cash Flow	11.63B
Capital Expenditures	-2.50B
Free Cash Flow	9.13B
FCF Per Share	73.08

Full Cash Flow Statement

Margins

Gross margin is 74.56%, with operating and profit margins of 25.16% and 19.48%.

Gross Margin	74.56%
Operating Margin	25.16%
Pretax Margin	26.31%
Profit Margin	19.48%
EBITDA Margin	27.83%
EBIT Margin	25.16%
FCF Margin	20.32%

Dividends & Yields

This stock pays an annual dividend of 56.00, which amounts to a dividend yield of 2.00%.

Dividend Per Share	56.00
Dividend Yield	2.00%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	37.41%
Buyback Yield	1.05%
Shareholder Yield	3.05%
Earnings Yield	2.48%
FCF Yield	2.61%

Dividend Details

Stock Splits

The last stock split was on June 22, 2022. It was a forward split with a ratio of 1.5.

Last Split Date	Jun 22, 2022
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a